Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34269
Abstract: Pancreatic adenocarcinoma (PDAC) remains a refractory disease; however, modern cytotoxic chemotherapeutics can induce tumor regression and extend life. A bloodâbased, pharmacogenomic, chemosensitivity assay using gene expression profiling of circulating tumor and invasive cells (CTICs) to… read more here.
Keywords: circulating tumor; tumor invasive; therapy; expression profiling ... See more keywords